CENTER OF MOLECULAR IMMUNOLOGY(CIM).CIMAB
Trials shown by sponsor
Public title | Date of Registration | State |
---|---|---|
Study of intensive pediatric pharmacovigilance of nimotuzumab for the treatment of malignant glioma tumors. | 14/08/2014 | Registered |
NeuroEPO-Stroke. Phase I-II | 11/09/2014 | Registered |
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II | 02/11/2014 | Registered |